Healthcare
Live Price
Offline$0.05
+0.00% today
1Y Change
-73.68%
Window
Jun 23, 2025 → Jun 18, 2026
Coverage: 249 bars · Jun 23, 2025 → Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Immutep Limited (PRRUF) is a Healthcare stock with a market cap of $90.00M and listed on OTC. The stock last traded around $0.05 and down 73.7% across the available one-year price window (Jun 23, 2025 → Jun 18, 2026). Baseline metrics include revenue growth of +31.3%, EPS growth of -18.5%, a dividend yield of 0.0%. What stands out right now is revenue +31.3%, EPS -18.5%, free cash flow -73.7% with operating margin -2052.2% and ROIC -122.1%. Valuation already assumes a fairly strong business story at price/sales 15.0. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines PRRUF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
PRRUF
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
PRRUF Max Drawdown
-87.50%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for PRRUF and SPY.
Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.
Dividend Yield
No active yield
Trailing 12M Payout
$0.00
Last Payout
—
Next Step
Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.